These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1334206)

  • 21. Magnetic resonance imaging of brain iron in health and disease.
    Vymazal J; Brooks RA; Patronas N; Hajek M; Bulte JW; Di Chiro G
    J Neurol Sci; 1995 Dec; 134 Suppl():19-26. PubMed ID: 8847541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration.
    Vymazal J; Hajek M; Patronas N; Giedd JN; Bulte JW; Baumgarner C; Tran V; Brooks RA
    J Magn Reson Imaging; 1995; 5(5):554-60. PubMed ID: 8574041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of contrast enhancement in magnetic resonance imaging.
    Lee DH
    Can Assoc Radiol J; 1991 Feb; 42(1):6-12. PubMed ID: 2001531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of magnetic field and iron content on NMR proton relaxation of liver, spleen and brain tissues.
    Hocq A; Luhmer M; Saussez S; Louryan S; Gillis P; Gossuin Y
    Contrast Media Mol Imaging; 2015; 10(2):144-52. PubMed ID: 24954138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of diffusion in ferritin-induced relaxation enhancement of protons.
    Boss MA; Chris Hammel P
    J Magn Reson; 2012 Apr; 217():36-40. PubMed ID: 22410189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single molecular functional assay of ferritin arrays.
    Yamaki M
    Adv Biophys; 1997; 34():191-203. PubMed ID: 9204135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths.
    Bulte JW; Miller GF; Vymazal J; Brooks RA; Frank JA
    Magn Reson Med; 1997 Apr; 37(4):530-6. PubMed ID: 9094074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis.
    Engelhardt R; Langkowski JH; Fischer R; Nielsen P; Kooijman H; Heinrich HC; Bücheler E
    Magn Reson Imaging; 1994; 12(7):999-1007. PubMed ID: 7997105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple approach to T2 imaging in MRI.
    Pope JM; Repin N
    Magn Reson Imaging; 1988; 6(6):641-6. PubMed ID: 2850433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T2 values in the human brain: comparison with quantitative assays of iron and ferritin.
    Chen JC; Hardy PA; Clauberg M; Joshi JG; Parravano J; Deck JH; Henkelman RM; Becker LE; Kucharczyk W
    Radiology; 1989 Nov; 173(2):521-6. PubMed ID: 2798884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcification can shorten T2, but not T1, at magnetic resonance imaging fields. Results of a relaxometry study of calcified human meningiomas.
    Tenner MS; Spiller M; Koenig SH; Valsamis MP; Childress S; Brown RD; Kasoff SS
    Invest Radiol; 1995 Jun; 30(6):345-53. PubMed ID: 7490186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled aggregation of ferritin to modulate MRI relaxivity.
    Bennett KM; Shapiro EM; Sotak CH; Koretsky AP
    Biophys J; 2008 Jul; 95(1):342-51. PubMed ID: 18326661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
    Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
    Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human isoferritins: organ specific iron and apoferritin distribution.
    Powell LW; Alpert E; Isselbacher KJ; Drysdale JW
    Br J Haematol; 1975 May; 30(1):47-55. PubMed ID: 811243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease.
    Chen JC; Hardy PA; Kucharczyk W; Clauberg M; Joshi JG; Vourlas A; Dhar M; Henkelman RM
    AJNR Am J Neuroradiol; 1993; 14(2):275-81. PubMed ID: 8456699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualization of brain iron by mid-field MR.
    Norfray JF; Couch JR; Elble RJ; Good DC; Manyam BV; Patrick JL
    AJNR Am J Neuroradiol; 1988; 9(1):77-82. PubMed ID: 3124588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classical and quantum magnetic phenomena in natural and artificial ferritin proteins.
    Gider S; Awschalom DD; Douglas T; Mann S; Chaparala M
    Science; 1995 Apr; 268(5207):77-80. PubMed ID: 7701343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging measurement of volume magnetic susceptibility using a boundary condition.
    Wang ZJ; Li S; Haselgrove JC
    J Magn Reson; 1999 Oct; 140(2):477-81. PubMed ID: 10497053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing ferritin from apoferritin using magnetic force microscopy.
    Nocera TM; Zeng Y; Agarwal G
    Nanotechnology; 2014 Nov; 25(46):461001. PubMed ID: 25355655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.